EMR migration validation

Migrations fail one field at a time.

ChartBridge validates every record on arrival, flags what's missing, and suggests the fix — before go-live.

Design partner slots are limited to a few EMR platforms and practices with an active migration.

What goes missing

Common failures. None of them throw an error.

Finding it is half the job

"Validation failed" isn't an answer. ChartBridge shows the gap, the cause, and the fix.

ALLERGY LIST · PATIENT 004821 source compared against imported record
SOURCE — LEGACY EMR
Penicillin — anaphylaxis
Sulfa drugs — rash
Latex — contact dermatitis
Iodine contrast — hives
DESTINATION — AS IMPORTED
Penicillin — anaphylaxis
Sulfa drugs — rash
not present
not present
WHAT HAPPENED
2 of 4 entries did not survive mapping.
WHY
Destination field accepts a two-item array. The remainder was truncated without error.
SUGGESTED FIX
Map to the multi-entry allergy table, restore from source, re-validate.
MOST TOOLS REPORT

Allergy list: validation failed. Review required.

CHARTBRIDGE REPORTS

Two entries dropped, field limit caused it, mapping change fixes it — applied across every record with the same signature.

Fixes are always suggested, never silent. Every change is approved and logged against a named user.

How it works

Five stages. Each catches a specific class of failure.

01

Audit

Inventory the source before anything moves.

Flags what the export won't include.
Output — source inventory
02

Triage

Rank exceptions by risk, propose a fix for each.

Prioritises what actually needs review.
Output — exception queue
03

Map & Clean

Normalise and map every field to its destination.

Catches silent mismatches and truncations.
Output — mapping spec
04

Import & Validate

Confirm every record against its source.

Verifies what the import reported as successful.
Output — readiness report
05

Query

Ask the migrated data in plain language.

Answers on day one, cited to source.
Output — answers, cited to source
For EMR Platforms

Onboard without inheriting the last system's data problems.

Sits inside your existing flow and delivers a clean record set with exceptions already surfaced.

For Clinics & Hospitals

Go live with proof of what came across.

Every record reconciled against source, with a readiness report ready for compliance.

The artefact you hand to compliance

A signed reconciliation: counts matched, exceptions accounted for, approvals named.

GO-LIVE READINESS REPORT
Northside Behavioral Health · Legacy EMR → New Platform
READY
CategorySourceImportedStatus
Patient demographics48,21048,210Reconciled
Encounters612,884612,884Reconciled
Medications184,027184,027Reconciled
Allergies39,55139,551Reconciled
Documents96,34096,3382 quarantined
EXCEPTIONS RAISED
1,284
RESOLVED BEFORE GO-LIVE
1,282
CARRIED WITH SIGN-OFF
2
Every exception approved by a named user. Full audit trail — who, when, source value, change — exports with the report.

Then ask it anything

Once validated, the data is queryable in plain language — by the migration team and by the clinic running on it Monday.

CLINIC · REVENUE CYCLE
› What's sitting in AR over 90 days, and did any of it shift during the migration?

$412,880 in AR over 90 days — matching the source system to the dollar.

0–30 days $1.34M
31–60 days $650K
61–90 days $300K
90+ days $413K
0outstanding balance
No balance changed during migration. Every ageing bucket reconciles to source — the 90+ figure is a collections issue, not a migration artefact.
Reconciled against 214,600 source ledger entries · as of go-live
CLINIC · PRACTICE MANAGER
› How many active patients haven't been seen in the last 12 months?

3,904 patients are marked active with no encounter since Aug 2025.

No future appointment 2,611
Open balance 488
Both 317
03,904 patients
Based on 48,210 migrated patient records · as of go-live

Every answer cites its source records, so anything surprising can be traced back — not taken on faith.

A migration isn't done when the import finishes.
It's done when you can prove nothing was lost.

Limited design partner slots. Direct access to both founders.

Request early access